Skip to main content
. 2022 Apr 27;31(9):2663–2671. doi: 10.1007/s11136-022-03136-9

Table 1.

Baseline characteristics of participants by polypharmacy status

Polypharmacy status
Overall (n = 2181) No polypharmacy
(n = 1351, 61.9%)
Baseline only polypharmacy
(n = 125, 5.7%)
Incident polypharmacy
(n = 245, 11.2%)
Persistent polypharmacy
(n = 460, 21.1%)
Demographics
 Age, mean (SD), years 72.8 (6.3) 71.9 (6.0) 74.0 (6.5) 74.2 (6.8) 74.2 (6.5)
 Female, n (%) 1195 (54.8) 740 (54.8) 75 (60.0) 127 (51.8) 253 (55.0)
 High school education or above, n (%) 1176 (53.9) 771 (57.1) 59 (47.2) 129 (52.7) 217 (47.1)
 Comorbidities at 2013, mean (SD) 1.66 (1.3) 1.15 (1.0) 2.14 (1.0) 1.78 (1.1) 2.96 (1.4)
 Comorbidities at 2017, mean (SD) 1.88 (1.4) 1.33 (1.0) 2.13 (1.1) 2.37 (1.2) 3.15 (1.5)
 Medications, mean (SD) 3.5 (3.1) 1.8 (1.3) 7.0 (2.8) 3.0 (1.2) 7.5 (2.8)
 Married, n (%) 1365 (62.6) 888 (65.7) 71 (56.8) 143 (58.4) 263 (57.2)
 Socialises > once a month. n (%) 1791 (82.1) 1132 (83.8) 93 (74.4) 197 (80.4) 369 (80.2)
 SEIFA- IRSAD, mean (SD) 5.4 (3.0) 5.6 (3.0) 4.8 (2.7) 5.2 (3.0) 4.7 (2.8)
 Physical activity ≥ 3 times a week, n (%) 1090 (50.0) 781 (57.8) 50 (40.0) 118 (48.2) 141 (30.7)
 Smoking, n (%) 131 (6.0) 73 (5.4) 7 (5.6) 21 (8.6) 30 (6.5)
 Alcohol intake ≥ 5 days per week, n (%) 574 (26.3) 374 (27.7 30 (24.0) 67 (27.3) 102 (22.2)
QoL summary measures
 PCS 43.8 (12.7) 48.1 (10.6) 38.6 (11.6) 41.3 (11.9) 33.3 (12.1)
 MCS 50.8 (11.5) 54.1 (9.7) 47.1 (11.8) 49.3 (10.5) 42.8 (12.6)
QoL measures, mean (SD)
 General health 63.94 (21.6) 71.4 (17.9) 57.8 (21.0) 59.2 (19.4) 46.2 (21.0)
 Mental health 78.5 (16.2) 81.8 (14.5) 75.2 (16.7) 77.6 (14.6) 70.4 (18.2)
 Physical functioning 68.3 (25.5) 76.5 (21.3) 59.2 (24.0) 64.1 (24.1) 48.5 (25.8)
 Social functioning 80.4 (24.5) 86.8 (20.6) 74.7 (25.5) 77.6 (23.0) 64.9 (27.9)
 Vitality 61.2 (20.0) 67.0 (17.7) 55.2 (19.2) 58.2 (18.4) 47.4 (19.7)
 Bodily pain 63.8 (25.0) 70.4 (22.2) 56.5 (24.9) 60.6 (24.2) 47.9 (25.3)
 Role-physical 60.4 (43.3) 72.7 (38.7) 43.3 (42.4) 53.2 (43.8) 32.5 (40.4)
 Role-emotional 80.1 (35.7) 87.0 (29.2) 69.1 (41.2) 78.2 (36.9) 63.9 (43.8)

SEIFA-IRSAD Socio-Economic Indexes for Areas-Index of Relative Socio-Economic Advantage and Disadvantage, SD standard deviation, QoL quality of life, PCS Physical component summary, MCS Mental component summary